|
|
Volumn 1, Issue 1, 2001, Pages 1-25
|
|
DNA topoisomerases as anticancer drug targets: from the laboratory to the clinic.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DNA TOPOISOMERASE;
ENZYME INHIBITOR;
APOPTOSIS;
CLINICAL TRIAL;
DNA DAMAGE;
DNA REPAIR;
DRUG ANTAGONISM;
DRUG RESISTANCE;
ENZYMOLOGY;
HUMAN;
NEOPLASM;
PATHOLOGY;
REVIEW;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CLINICAL TRIALS;
DNA DAMAGE;
DNA REPAIR;
DNA TOPOISOMERASES;
DRUG RESISTANCE, NEOPLASM;
ENZYME INHIBITORS;
HUMANS;
NEOPLASMS;
|
|
EID: 0009848001
PISSN: 15680118
EISSN: None
Source Type: Journal
DOI: 10.2174/1568011013354859 Document Type: Review |
|
Times cited : (123)
|
|
References (202)
|
